United states securities and exchange commission

Management’s Annual Report on Internal Control over Financial Reporting
The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting 
(as defined in Rule 13a-15(f) under the Exchange Act). Management conducted an assessment of the effectiveness of the 
Company’s internal control over financial reporting based on the criteria set forth in Internal Control – Integrated Framework 
issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). Based on the Company’s 
assessment, management has concluded that its internal control over financial reporting was effective as of September 24, 2022 
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in 
accordance with GAAP. The Company’s independent registered public accounting firm, Ernst & Young LLP, has issued an audit 
report on the Company’s internal control over financial reporting, which appears in Part II, Item 8 of this Form 10-K.
Changes in Internal Control over Financial Reporting
There were no changes in the Company’s internal control over financial reporting during the fourth quarter of 2022, which were 
identified in connection with management’s evaluation required by paragraph (d) of Rules 13a-15 and 15d-15 under the 
Exchange Act, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over 
financial reporting.
Apple Inc. | 2022 Form 10-K | 53

---

Item 9B. Other Information
Rule 10b5-1 Trading Plans
During the three months ended September 24, 2022, Katherine L. Adams, Timothy D. Cook, Luca Maestri, Deirdre O’Brien and 
Jeffrey Williams, each an officer for purposes of Section 16 of the Exchange Act, had equity trading plans in place in accordance 
with Rule 10b5-1(c)(1) under the Exchange Act. An equity trading plan is a written document that preestablishes the amounts, 
prices and dates (or formula for determining the amounts, prices and dates) of future purchases or sales of the Company’s stock, 
including sales of shares acquired under the Company’s employee and director equity plans.